FDA approves Eli Lilly's drug for eczema

 Eli Lilly (LLY.N), opens new tab said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above 12 years old.

The drug, which is an injectable medicine and branded Ebglyss, will be available in the next few weeks, the company said.